Onco-Innovations Completes Private Placement Raising $1.2 Million

Onco-Innovations Limited has announced the successful closure of its non-brokered private placement, generating total proceeds of $1,215,500. The transaction involved the issuance of 1,870,000 units at $0.65 each. Each unit comprises one common share and one purchase warrant, allowing the purchase of an additional share at $0.75 until March 12, 2029.

Funds raised will support corporate objectives, including research and development, and investor relations. The transaction includes the issuance of administrative shares to a third party for services rendered. All securities are subject to a statutory hold period, and offerings in the U.S. are restricted without proper registration or exemption. Onco-Innovations emphasizes operational growth through this funding round.